Detection of increased scyllo-inositol in brain with magnetic resonance spectroscopy after dietary supplementation in Alzheimer's disease mouse models.
There is evidence that inositol isomers may help protect against formation of toxic fibrils of Abeta fragments in Alzheimer's disease mouse models. Scyllo-inositol is one of the more promising inositol isomers for the potential treatment of Alzheimer's disease (AD) and can be detected using MRS in human subjects. In this manuscript we demonstrate using MRS, in two different mouse models of AD (APP x PS1 and APP x PS1 x tau), that we could detect increased scyllo-inositol in the hippocampus and frontal cortex in mice fed water supplemented with 16.5 mg/L of scyllo-inositol equivalent to about 3.3 mg/kg/day. We used both brain extracts using solution MRS as well as intact brain tissue using high resolution magic angle spinning (HRMAS) to ensure that any membrane-associated scyllo-inositol would be detected. By brain extracts we detected a 3.0 fold increase in scyllo-inositol in the scyllo-fed AD mice compared to normal diet (p < 0.001). Using HRMAS we detected a 2.2-2.4-fold increase in scyllo-inositol (p < 0.001). Scyllo-inositol treatment was associated with an increase in glutamine in hippocampus. The concentrations of scyllo-inositol were higher in the hippocampus than in the frontal cortex. Mice have a smaller concentration of scyllo-inositol than humans (ca. 100 microM vs. 500 microM in humans). Given the ease with which scyllo-inositol can be measured in human MRS data with high signal to noise ratios, these data suggest that MRS will prove useful for evaluation of inositol treatment trials in AD subjects.
Choi
Ji-Kyung
JK
A A Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Charlestown, Boston, MA 02114, USA. jchoi@nmr.mgh.harvard.edu
Carreras
Isabel
I
Dedeoglu
Alpaslan
A
Jenkins
Bruce G
BG
D000544:Alzheimer Disease / Q000178:diet therapy / Q000378:metabolism*; D000818:Animals; D001921:Brain / Q000378:metabolism*; D019587:Dietary Supplements; D004195:Disease Models, Animal; D005260:Female; D006801:Humans; D007294:Inositol / Q000008:administration & dosage / Q000096:biosynthesis / Q000378:metabolism*; D009682:Magnetic Resonance Spectroscopy / Q000379:methods; D051379:Mice; D008822:Mice, Transgenic; D053764:Presenilin-1 / Q000235:genetics / Q000378:metabolism
D053764:Presenilin-1; C009217:scyllitol; D007294:Inositol
Neurobiol Dis. 2005 Feb;18(1):32-9
15649694
Dev Neurosci. 1993;15(3-5):289-98
7805581
J Neurochem. 2000 May;74(5):2108-19
10800956
Pediatr Res. 1989 Nov;26(5):482-5
2812900
Ann N Y Acad Sci. 1997 Sep 26;826:282-306
9329700
J Neuropathol Exp Neurol. 1997 Apr;56(4):321-39
9100663
Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11906-10
16091461
Nat Med. 2006 Jul;12(7):801-8
16767098
J Mol Med (Berl). 2007 Jun;85(6):603-11
17279347
Neurobiol Aging. 1996 May-Jun;17(3):349-57
8725895
NMR Biomed. 2007 May;20(3):216-37
17451183
Magn Reson Med. 1998 Feb;39(2):313-6
9469716
NMR Biomed. 1993 Jan-Feb;6(1):105-9
8384468
Radiology. 1995 Apr;195(1):65-72
7892497
Science. 1996 Oct 4;274(5284):99-102
8810256
Brain Res. 2002 Jan 11;924(2):133-40
11750898
J Biol Chem. 2006 Dec 22;281(51):39413-23
17056594
Brain Res. 2004 Jun 25;1012(1-2):60-5
15158161
J Biol Chem. 2000 Jun 16;275(24):18495-502
10764800
NMR Biomed. 2007 Dec;20(8):709-16
17295394
Neuron. 2003 Jul 31;39(3):409-21
12895417
Neurochem Res. 1999 Jan;24(1):51-9
9973237
Exp Neurol. 2010 Jun;223(2):377-84
19679126
J Neurochem. 1978 Oct;31(4):1113-5
702143